Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.197 EUR 3.96% Market Closed
Market Cap: €14.3m

Net Margin

-79.6%
Current
Declining
by 38.3%
vs 3-y average of -41.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-79.6%
=
Net Income
€-2.1m
/
Revenue
€2.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-79.6%
=
Net Income
€-2.1m
/
Revenue
€2.6m

Peer Comparison

Country Company Market Cap Net
Margin
ES
Biotechnology Assets SA
MAD:BST
13.4m EUR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

Lower than 95% of companies in Spain
Percentile
5th
Based on 821 companies
5th percentile
-79.6%
Low
-9 204.1% — 1.8%
Typical Range
1.8% — 19%
High
19% — 603.4%
Distribution Statistics
Spain
Min -9 204.1%
30th Percentile 1.8%
Median 7.6%
70th Percentile 19%
Max 603.4%

Biotechnology Assets SA
Glance View

Market Cap
14.3m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-79.6%
=
Net Income
€-2.1m
/
Revenue
€2.6m
What is Biotechnology Assets SA's current Net Margin?

The current Net Margin for Biotechnology Assets SA is -79.6%, which is below its 3-year median of -41.3%.

How has Net Margin changed over time?

Over the last 3 years, Biotechnology Assets SA’s Net Margin has decreased from -78% to -79.6%. During this period, it reached a low of -116% on Dec 31, 2024 and a high of 78.5% on Jun 30, 2023.

Back to Top